Abstract:PTEN on 10q23.3 encodes a dual-specificity phosphatase that negatively regulates the phosphoinositol-3-kinase/Akt pathway and mediates cell-cycle arrest and apoptosis. Germline PTEN mutations cause Cowden syndrome and a range of several different hamartoma-tumor syndromes. Hereditary nonpolyposis colon cancer (HNPCC) syndrome is characterized by germline mutations in the mismatch repair (MMR) genes and by microsatellite instability (MSI) in component tumors. Although both colorectal carcinoma and endometrial carcinoma are the most frequent component cancers in HNPCC, only endometrial cancer has been shown to be a minor component of Cowden syndrome. We have demonstrated that somatic inactivation of PTEN is involved in both sporadic endometrial cancers and HNPCC-related endometrial cancers but with different mutational spectra and different relationships to MSI. In the current study, we sought to determine the relationship of PTEN mutation, 10q23 loss of heterozygosity, PTEN expression, and MSI status in colorectal cancers (CRCs). Among 11 HNPCC CRCs, 32 MSI+ sporadic cancers, and 39 MSI- tumors, loss of heterozygosity at 10q23.3 was found in 0%, 8%, and 19%, respectively. Somatic mutations were found in 18% (2 of 11) of the HNPCC CRCs and 13% (4 of 32) of the MSI+ sporadic tumors, but not in MSI- cancers (P = 0.015). All somatic mutations occurred in the two 6(A) coding mononucleotide tracts in PTEN, suggestive of the etiological role of the deficient MMR. Immunohistochemical analysis revealed 31% (14 of 45) of the HNPCC CRCs and 41% (9 of 22) of the MSI+ sporadic tumors with absent or depressed PTEN expression. Approximately 17% (4 of 23) of the MSI- CRCs had decreased PTEN expression, and no MSI- tumor had complete loss of PTEN expression. Among the five HNPCC or MSI+ sporadic CRCs carrying frameshift somatic mutations with immunohistochemistry data, three had lost all PTEN expression, one showed weak PTEN expression levels, and one had mixed tumor cell populations with weak and moderate expression levels. These results suggest that PTEN frameshift mutations in HNPCC and sporadic MSI+ tumors are a consequence of mismatch repair deficiency. Further, hemizygous deletions in MSI- CRCs lead to loss or reduction of PTEN protein levels and contribute to tumor progression. Finally, our data also suggest that epigenetic inactivation of PTEN, including differential subcellular compartmentalization, occurs in CRCs.

PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival

The Clinical Significance of PTEN Protein Expression in Colorectal Carcinoma

Loss of PTEN Expression Predicts Resistance to EGFR-targeted Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer

Functions and Regulation of the PTEN Gene in Colorectal Cancer

Clinical significance of tumor suppressor PTEN in colorectal carcinoma

PTEN Mutational Spectra, Expression Levels, and Subcellular Localization in Microsatellite Stable and Unstable Colorectal Cancers

Expression of PPARγ and PTEN in Human Colorectal Cancer: an Immunohistochemical Study Using Tissue Microarray Methodology.

Loss of PTEN Expression in Breast Cancer: Association with Clinicopathological Characteristics and Prognosis

PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target

Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers

PTEN mutations are common in sporadic microsatellite stable colorectal cancer

The Clinicopathological Correlation of KRAS Mutation and PTEN Expression Status in Primary and Metastatic Colorectal Carcinoma

Pten Loss Increases Pd-L1 Protein Expression And Affects The Correlation Between Pd-L1 Expression And Clinical Parameters In Colorectal Cancer

PTEN status in advanced colorectal cancer treated with cetuximab

Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer

KRAS, BRAF and PIK3CA Mutations and the Loss of PTEN Expression in Chinese Patients with Colorectal Cancer.

Phosphatase and Tensin Homolog Expression Related to Cetuximab Effects in Colorectal Cancer Patients: a Meta-Analysis.

Concordant analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression between primary colorectal cancer and matched metastases.

Loss of Phosphatase and Tensin Homolog Expression Correlates with Clinicopathological Features of Non-Small Cell Lung Cancer Patients and Its Impact on Survival: A Systematic Review and Meta-Analysis

Phosphatase and Tensin Homolog (PTEN) Expression on Oncologic Outcome in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis

PTEN expression is a prognostic marker for patients with non-small cell lung cancer: a systematic review and meta-analysis of the literature